Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.34B |
| 2 |
Broadcom
AVGO
|
+$953M |
| 3 |
RTX Corp
RTX
|
+$883M |
| 4 |
CVS Health
CVS
|
+$771M |
| 5 |
Nike
NKE
|
+$768M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.48B |
| 2 |
Public Storage
PSA
|
+$1.29B |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.18B |
| 4 |
Entergy
ETR
|
+$737M |
| 5 |
Qualcomm
QCOM
|
+$705M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.22% |
| 2 | Financials | 14.36% |
| 3 | Industrials | 13.12% |
| 4 | Healthcare | 12.96% |
| 5 | Communication Services | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Rexford Industrial Realty
REXR
$8.12B
| $140M | 0.03% |
+2,487,023
| New | +$122M |
|
252
AB InBev
BUD
$158B
| $137M | 0.03% |
2,124,860
+18,280
| +0.9% | +$1.08M |
|
253
Agilon Health
AGL
$1.5B
| $137M | 0.03% |
437,385
+60,879
| +16% | +$22M |
|
254
Enerpac Tool Group
EPAC
$1.88B
| $135M | 0.03% |
4,347,380
+118,691
| +3% | +$3.39M |
|
|
CTLT
255
DELISTED
CATALENT, INC.
CTLT
| $135M | 0.03% |
2,994,467
+34,856
| +1% | +$1.41M |
|
256
NovoCure
NVCR
$2.05B
| $132M | 0.03% |
8,861,871
-142,621
| -2% | -$1.91M |
|
257
Olin
OLN
$2.17B
| $131M | 0.03% |
2,431,272
-5,212,743
| -68% | -$250M |
|
258
Global Payments
GPN
$24.2B
| $131M | 0.03% |
1,031,108
+13,189
| +1% | +$1.53M |
|
259
Genmab
GMAB
$19.2B
| $130M | 0.03% |
4,057,922
-260,420
| -6% | -$8.18M |
|
260
Moody's
MCO
$82.9B
| $129M | 0.03% |
329,729
+122
| +0% | +$42.4K |
|
261
Evertec
EVTC
$1.86B
| $128M | 0.03% |
3,131,941
+1,209
| +0% | +$44.4K |
|
262
Novanta
NOVT
$6.36B
| $127M | 0.03% |
755,395
-189,439
| -20% | -$27.6M |
|
263
ESCO Technologies
ESE
$7.78B
| $126M | 0.03% |
1,076,662
-80,000
| -7% | -$8.41M |
|
264
Vestis
VSTS
$1.85B
| $126M | 0.03% |
+5,940,705
| New | +$102M |
|
265
Stellantis
STLA
$20.1B
| $123M | 0.03% |
5,241,826
-1,818,604
| -26% | -$37.6M |
|
266
Accenture
ACN
$109B
| $117M | 0.03% |
+333,287
| New | +$107M |
|
267
BP
BP
$110B
| $116M | 0.03% |
3,293,482
+588,029
| +22% | +$21.5M |
|
268
Intuit
INTU
$92.9B
| $115M | 0.03% |
183,716
+49
| +0% | +$27K |
|
269
Alkami Technology
ALKT
$2.16B
| $113M | 0.03% |
4,679,907
+632,061
| +16% | +$13.2M |
|
270
Xenon Pharmaceuticals
XENE
$6.2B
| $113M | 0.03% |
2,455,683
+8,863
| +0.4% | +$313K |
|
271
Essent Group
ESNT
$6.17B
| $111M | 0.02% |
2,108,994
| – | – |
|
272
Floor & Decor
FND
$6.31B
| $110M | 0.02% |
989,703
-23
| -0% | -$2.12K |
|
273
Legend Biotech
LEGN
$3.96B
| $110M | 0.02% |
1,824,687
-8,116
| -0.4% | -$514K |
|
274
Datadog
DDOG
$90B
| $109M | 0.02% |
897,186
| – | – |
|
275
Guardant Health
GH
$21.6B
| $108M | 0.02% |
4,001,803
+1,074,452
| +37% | +$28.2M |
|
Similar funds
Capital International Investors's Q4 2023 Portfolio in Review
As of Q4 2023, Capital International Investors held 458 positions worth $446B, up 13% from $394B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital International Investors's Q4 2023 filing shows 24 new, 191 increased, 162 reduced and 20 closed positions. Its largest new stake was TransUnion: 9,649,264 shares worth $663M. The largest sale was Edwards Lifesciences, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Capital International Investors's largest Q4 2023 buy was TransUnion: 9,649,264 shares worth $663M.
- Capital International Investors added most to Salesforce in Q4 2023, an estimated $1.34B increase.
- Capital International Investors's biggest Q4 2023 reduction was Edwards Lifesciences, cutting an estimated $1.48B.
- Capital International Investors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $389M.
- Capital International Investors's ten largest holdings make up 29% of its $446B portfolio in Q4 2023.
- Capital International Investors opened 24 new positions and closed 20 in Q4 2023.
- Capital International Investors's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Capital International Investors's 13F filing for Q4 2023, filed 13 Feb 2024.